Bijal Kakrecha

Statistics

Publications

Citations

231

H-Index

Active since

2016

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Pennsylvania

Bijal Kakrecha is an author at Bristol-Myers Squibb (United States) specializing in oncology, checkpoint inhibitor therapy, and immune checkpoint inhibitors.

Publications per year

2016–2018

Publications

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer

Nataly Manjarrez‐Orduño, Laurence Ménard, Selena Kansal et al. · Frontiers in Immunology · 2018 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17

Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers

Laurence Ménard, Paul Fischer, Bijal Kakrecha et al. · Frontiers in Immunology · 2018 · 54 citations · Full text

Life Sciences, Immunology, Oncology +17

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Kara N. Maxwell, Danielle Soucier-Ernst, Emin Tahirović et al. · Breast Cancer Research and Treatment · 2017 · 27 citations · Full text

Medicine, Genetics, Oncology +17

A novel approach for next‐generation sequencing of circulating tumor cells

Stephanie S. Yee, David Lieberman, Tatiana Blanchard et al. · Molecular Genetics & Genomic Medicine · 2016 · 21 citations · Full text

Medicine, Oncology, Cancer Genetics +14

1–4 of 4